Chitotriosidase activity in sarcoidosis and some other pulmonary diseases

References

• Korolenko TA, Zhanaeva S Ya, Falameeva OV, Kaledin VI, Filyushina EF, Buzeva II, Paul GA. Chitotriosidase as a marker of macrophage stimulation. Bull Exp Biol Med. 2000; 130:948–50.
   PubMed Web of Science ®Google Scholar
• Malaguranera L. Chitotriosidase: the yin and yang. Cell Molec Sci. 2006; 63:3018–29.
   PubMedGoogle Scholar
• van Eijk M, van Roomen CPAA, Renkema GH, Bussink AP, Andrews L, Blooaart EFC, Sugar A, Verhoeven AJ, Boot RG, Aerts JMFG. Characterization of human phagocyte derived chitotriosidase, a component of innate immunity. Int Immunol. 2005; 17:1505–12.
   PubMed Web of Science ®Google Scholar
• Hollak CEM, van Weely S, van Oers MHJ, Aerts JMF. Marked elevation of plasma chitotriosidase activity. A novel hallmark of Gaucher Disease. J Clin Invest. 1994; 93:1288–92.
   PubMed Web of Science ®Google Scholar
• Barone R, Sotgiu S, Musumeci S. Plasma chitotriosidase in health and pathology. Clin Lab. 2007; 53:321–33.
   PubMed Web of Science ®Google Scholar
• Grosso S, Margollicci M, Bargagli E, Buccoliero R, Perrone A, Galimberti D, Morgese C, Balestri P, Rottoli P. Serum levels of chitotriosidase as a marker of disease activity and clinical stage in sarcoidosis. Scand J Clin Lab Invest. 2004; 64:57–62.
   PubMed Web of Science ®Google Scholar
• Bargagli E, Margollicci M, Nikiforakis N, Luddi A, Perrone A, Grosso S, Rottoli P. Chitotriosidase activity in the serum of patients with sarcoidosis and pulmonary tuberculosis. Respiration. 2007; 74:548–52.
   PubMed Web of Science ®Google Scholar
• Bargagli E, Margollicci M, Luddi A, Nikiforakis N, Perari MG, Grosso S, Perrone A, Rottoli P. Chitotriosidase activity in patients with interstitial lung diseases. Resp Med. 2007; 101:2176–81.
   PubMed Web of Science ®Google Scholar
• Statement on sarcoidosis. Joint statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and other Granulomatous Disorders (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee, February 1999. Am J Respir Crit Care Med. 1999; 160:736–55.
   PubMed Web of Science ®Google Scholar
• Kasahara Y, Ashikara Y. Colorimetry of angiotensin-1 converting enzyme activity in serum. Clin Chem. 1981; 27:1922–5.
   PubMed Web of Science ®Google Scholar
• Bargagli E, Bianchi N, Margolicci M, Olivieri C, Luddi A, Coviello G, Grosso S, Rottoli P. Chitotriosidase and soluble IL-2 receptor: comparison of two markers of sarcoidosis. Scand J Clin Lab Invest. 2008; 68:479–83.
   PubMed Web of Science ®Google Scholar
• Hill TA, Lightman S, Pantelidis T, Abdallah A, Spangolo P, du Bois RM. Intracellular cytokine profiles and T-cell activation in pulmonary sarcoidosis. Cytokine. 2008; 42:289–92.
   PubMed Web of Science ®Google Scholar
• Terčelj M, Rott T, Rylander R. Antifungal treatment in sarcoidosis-a pilot intervention study. Resp Med. 2007; 101:774–8.
   PubMed Web of Science ®Google Scholar
• Terčelj M, Salobir B, Rylander R. Microbial antigen treatment in sarcoidosis-a new paradigm?. Medical Hypothesis. 2008; 70:831–4.
   PubMedGoogle Scholar
• Hong F, Yan J, Baran JT, Allendorf DJ, Hansen RD, Ostroff GR, Xing PX, Cehung N-KV, Ross GD. Mechanism by which orally administered β-1,3-glucan enhances the tumoricidal activity of antitumor monoclonal antibodies in murine tumor models. J Immunol. 2004; 173:797–806.
   PubMed Web of Science ®Google Scholar
• Boot RG, Renkema GH, Verhoekt M, Strijland A, Bliek J, Maurice T, de Meulemeester AM, Mannens MA, Aerts JG. The human chitotriosidase gene. Nature of inherited enzyme deficiency. J Biol Chem. 1998; 273:25680–5.
   PubMed Web of Science ®Google Scholar
• Chupp GL, Lee CG, Jarjour N, Shim YM, Holm CT, He S, Dziura JD, Reed J, Coyle AJ, Kiener P, Cullen M, Grandsaigne, Dombret M-C, Aubier M, Pretolani M, Elias JA. A chitinase-like protein in the lung and circulation of patients with severe asthma. N Engl J Med. 2007; 357:2016–27.
   PubMed Web of Science ®Google Scholar
• Ober C, Tan Z, Sun Y, Possick JD, Pan L, Nicolae R, Radford S, Parry RR, Heinzmann A, Deichmann KA, Lester LA, Gern JE, Lemanske RF, Nicolae DL, Elias JA, Chupp GL. Effect of variation in CHI3L1 on serum YKL-40 level, risk of asthma, and lung function. N Engl J Med. 2008; 358:1682–91.
   PubMed Web of Science ®Google Scholar
• Artieda M, Cenarro A, Gaňán A, Lukic A, Moreno E, Puzo J, Pocovi M, Civeira F. Serum chitotriosidase activity, a marker of activated macrophages, predicts new cardio vascular events independently of C-reactive protein. Cardiology. 2007; 108:297–306.
   PubMedGoogle Scholar